Reuters exclusively reports Sanofi poised to appoint Novartis’ Hudson as CEO

06 June 2019, 12:00 am 1 minute

Reuters exclusively reported that Sanofi is poised to appoint Paul Hudson, a top executive with Switzerland’s Novartis, to become the French drugmaker’s next CEO from Sept. 1. Reuters had reported on March 18 Sanofi was working to find a successor to Brandicourt.

Article Tags

Type: Reuters Best

Sectors: Equities

Regions: Europe / Middle East / Africa

Share this article

Work Email Address *

Country *

I'd like to receive communications about Reuters resources, events, products, or services.

(Please note you can manage and update your preferences at any time.) By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement.

By submitting your details, you are agreeing to receive communications about Reuters resources, events, products, or services. By submitting your details, you are also acknowledging that you have read and understood our: Privacy Statement. * required field

Work Email Address *

Country *

More of Reuters Best

UAE’s ADNOC recently eyed BP as takeover target

Reuters exclusively reports Sanofi poised to appoint Novartis’ Hudson as CEO

More of Reuters Best

UAE’s ADNOC recently eyed BP as takeover target

EU’s new tech laws are working – small browsers gain market share

Thai PM says central bank should cut rates to help economic revival

Bank of Korea considering forward guidance overhaul